Grzegorz Goñda
Profile
Mr. Grzegorz Goñda is on the Board of Directors at ERNE VENTURES SA.
Mr. Goñda was previously employed as an Analyst by KBC Securities NV.
Former positions of Grzegorz Goñda
| Companies | Position | End |
|---|---|---|
| KBC Securities NV (Poland) | Analyst-Equity | 31/01/2005 |
| ERNE VENTURES SA | Director/Board Member | - |
Experiences
Positions held
Linked companies
| Private companies | 2 |
|---|---|
Erne Ventures SA
 Erne Ventures SA Specialty StoresRetail Trade Erne Ventures SA is a clinical stage biopharmaceutical company, which engages in the research and development of oncology therapeutics. Its drug candidates include the following: RX-31171 for pancreatic, bladder, colon, and lung cancer; RX-5902 or Supinoxin for metastatic triple negative breast cancer; and RX-0201 or Archexin for renal cell carcinoma, glioblastoma, ovarian, stomach, and pancreatic cancer. It also develops nano-based drug delivery systems. The company was founded by Arkadiusz Stefan Kuich in September 2007 and is headquartered in Warszawa, Poland. | Retail Trade |
| KBC Securities NV (Poland) | Finance |
- Stock Market
- Insiders
- Grzegorz Goñda
